2016 (3) TMI 350 - AT - Central Excise

Ayurvedic Medicines Classified under Heading 3003.31 Upheld with Exemption

The Tribunal upheld the classification of Ayurvedic medicines under heading 3003.31, granting the exemption available to such medicaments. It dismissed ... Classification of Ayurvedic medicaments - tariff classification under Heading 3003.31 versus Heading 3003.39 - patent or proprietary medicament - manufactured in accordance with authoritative Ayurvedic texts - sale under the name specified in authoritative texts - house mark versus product name - exemption for Ayurvedic medicamentsClassification of Ayurvedic medicaments - tariff classification under Heading 3003.31 versus Heading 3003.39 - patent or proprietary medicament - manufactured in accordance with authoritative Ayurvedic texts - sale under the name specified in authoritative texts - house mark versus product name - exemption for Ayurvedic medicaments - Whether the Ayurvedic medicines manufactured and sold by the assessee are classifiable under Tariff Heading 3003.31 (and entitled to exemption) or as patent/proprietary medicaments under Tariff Heading 3003.39. - HELD THAT: - The admitted facts establish that the products are manufactured in accordance with formulae described in authoritative Ayurvedic texts and that the names specified in those texts appear on the product packaging. The contention that the presence of the assessee's trade/house mark and a registered design (brand name) converts the products into patent or proprietary medicaments is unsustainable. Heading 3003.31 requires manufacture according to authoritative formulae and sale under the name specified in those texts; it does not mandate exclusive use of that name to the exclusion of any manufacturer's mark. Prior decisions and administrative clarification (as considered by the Tribunal) support that a house name or logo on the label does not disentitle a product to classification as an Ayurvedic medicament when the substantive conditions of the heading are met. A monograph or marking identifying the manufacturer does not convert an Ayurvedic product into a proprietary medicament. Applying these principles to the facts, the Tribunal concluded that the products meet the requirements of Heading 3003.31 and are eligible for the exemption applicable to Ayurvedic medicaments. [Paras 6, 7]Products held classifiable under Tariff Heading 3003.31 and entitled to exemption; appeals of revenue dismissed and appeals of assessee allowed.Final Conclusion: The Tribunal allowed the assessee's appeals, holding that the Ayurvedic products manufactured as per authoritative texts and bearing the names specified therein - notwithstanding the presence of the manufacturer's house mark or logo - are classifiable under Heading 3003.31 and entitled to the exemption; the Department's appeals were dismissed. Issues:Classification of Ayurvedic medicines under tariff headings 3003.31 and 3003.39, fulfillment of conditions for classification, dispute regarding the name under which medicines are sold, applicability of specific and non-specific tariff headings, interpretation of trade names and proprietary medicines.Analysis:The judgment addressed three appeals dealing with the classification of Ayurvedic medicines under tariff headings 3003.31 and 3003.39. The appellant/assessee manufactured various Ayurvedic medicines like Neem, Boswellia, Serrata, Ashwagandha, Gymnema, etc., claiming full exemption under heading 3003.31. Revenue argued for classification under heading 3003.39 as 'Patent or Proprietary Medicament' due to trade names 'Sivananda' and 'Om' associated with the products.In the initial proceedings, the original authority classified the products under heading 3003.39, imposing duty liability and penalties. The Commissioner (Appeals) upheld this decision, leading to the appellant's appeal. Additionally, two other proceedings regarding Chawanprash and other Ayurvedic medicines under heading 3003.31 were also discussed, with the Revenue filing appeals against the Commissioner's decisions.The appellant's counsel argued that all medicines were manufactured as per Ayurvedic texts, meeting conditions for classification under heading 3003.31. They contended that the Commissioner did not consider relevant submissions and cited precedents supporting their classification. The Revenue highlighted trade names on product labels, suggesting proprietary medicines based on the company's branding.After hearing both sides and examining the records, the Tribunal focused on whether the medicines were sold under the specified names in authoritative Ayurvedic texts. It noted the absence of a specific heading for exclusively Ayurvedic patent or proprietary medicaments, leading to classification under the residual heading 3003.39 only when specific headings are inapplicable. The Tribunal emphasized that the products met the conditions for heading 3003.31, despite being sold with brand names like 'Sivananda' and 'Om.'Citing precedents and CBEC clarifications, the Tribunal emphasized that the presence of house names or brand logos does not disqualify products from Ayurvedic classification. It differentiated between house marks and product marks, concluding that mere identification of the manufacturer does not make the medicine proprietary. Consequently, the Tribunal allowed the appellant's appeal for classification under heading 3003.31 and dismissed the Revenue's appeals based on the same reasoning.In the final pronouncement, the Tribunal upheld the classification of Ayurvedic medicines under heading 3003.31, granting the exemption available to such medicaments, and dismissed the Revenue's appeals accordingly.